| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA59123
Max Phase: Preclinical
Molecular Formula: C20H25N5
Molecular Weight: 335.46
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: c1ccc(C(CCNCCCCc2c[nH]cn2)c2ccccn2)nc1
Standard InChI: InChI=1S/C20H25N5/c1(7-17-15-22-16-25-17)4-11-21-14-10-18(19-8-2-5-12-23-19)20-9-3-6-13-24-20/h2-3,5-6,8-9,12-13,15-16,18,21H,1,4,7,10-11,14H2,(H,22,25)
Standard InChI Key: MZHVMDYMNLXYAE-UHFFFAOYSA-N
Associated Targets(non-human)
Histamine H1 receptor 251 Activities
Histamine H3 receptor 1015 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 335.46 | Molecular Weight (Monoisotopic): 335.2110 | AlogP: 3.33 | #Rotatable Bonds: 10 |
| Polar Surface Area: 66.49 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 10.33 | CX LogP: 2.42 | CX LogD: -0.41 |
| Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.56 | Np Likeness Score: -0.51 |
References
| 1. Aslanian R, Mutahi Mw, Shih NY, Piwinski JJ, West R, Williams SM, She S, Wu RL, Hey JA.. (2003) Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine., 13 (12): [PMID:12781173] [10.1016/s0960-894x(03)00357-3] |
Source
Source(1):